The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(1-(3,5-dimethoxybenzyl)-1H-indazol-6-yl)-1-methyl-3-(methylamino)pyridin-2(1H)-one ID: ALA4533819
PubChem CID: 155546897
Max Phase: Preclinical
Molecular Formula: C23H24N4O3
Molecular Weight: 404.47
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CNc1cc(-c2ccc3cnn(Cc4cc(OC)cc(OC)c4)c3c2)cn(C)c1=O
Standard InChI: InChI=1S/C23H24N4O3/c1-24-21-9-18(14-26(2)23(21)28)16-5-6-17-12-25-27(22(17)10-16)13-15-7-19(29-3)11-20(8-15)30-4/h5-12,14,24H,13H2,1-4H3
Standard InChI Key: BBYODNXYGZVTRI-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 33 0 0 0 0 0 0 0 0999 V2000
17.4568 -23.0134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4556 -23.8329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1637 -24.2419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1619 -22.6045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8705 -23.0098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8753 -23.8284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6553 -24.0769 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.1327 -23.4117 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.6476 -22.7523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7495 -24.2412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0418 -23.8304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3343 -24.2377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3332 -25.0558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0455 -25.4648 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7502 -25.0551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9124 -24.8526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7127 -25.0178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9645 -25.7936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7640 -25.9590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3081 -25.3482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0473 -24.5693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2484 -24.4075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0478 -26.2820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6271 -23.8282 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6257 -25.4648 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.6281 -23.0110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5884 -23.9569 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.3893 -24.1194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0206 -26.7348 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.4771 -27.3450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 15 1 0
15 10 2 0
2 10 1 0
7 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
14 23 1 0
12 24 1 0
13 25 2 0
24 26 1 0
21 27 1 0
27 28 1 0
19 29 1 0
29 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 404.47Molecular Weight (Monoisotopic): 404.1848AlogP: 3.51#Rotatable Bonds: 6Polar Surface Area: 70.31Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.72CX LogP: 2.16CX LogD: 2.16Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.53Np Likeness Score: -1.11
References 1. Rong J, Feng ZZ, Shi YJ, Ren J, Xu Y, Wang NY, Xue Q, Liu KL, Zhou SY, Wei W, Yu LT.. (2019) Design, synthesis and biological evaluation of 3,5-dimethylisoxazole and pyridone derivatives as BRD4 inhibitors., 29 (19): [PMID:31421967 ] [10.1016/j.bmcl.2019.07.036 ]